ELV

Elevance Health
D

ELV

Arincen57/100B

Elevance Health earnings

Elevance Health reports its Q4 FY2026 results on 27 January 2027, before the market opens. Analysts expect earnings per share of 2.08 USD and revenue of 49.38B USD.

In Q3 FY2026, reported on 21 October 2026, Elevance Health earned 6.99 USD a share against the 4.71 USD analysts expected (+48.4%), on revenue of 50.44B USD against 49.28B USD (+2.4%).

Last EPS surprise
+48.4%
Last revenue surprise
+2.4%
Move after the last report
-1.4%
Average move after earnings
3.7%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
2.08 USD
Revenue estimate
49.38B USD
Last quarter · Q3 FY2026
EPS6.99Beat +48.4%Revenue50.44BBeat +2.4%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20276.15——-11.96%51.54B——+2.18%—
Q2 FY20278.18——+9.75%51.16B——+2.67%—
Q1 FY202712.41——-1.36%50.53B——+2.10%—
Q4 FY20262.08——-37.54%49.38B——+0.13%—
Q3 FY20264.716.99+48.41%+15.92%49.28B50.44B+2.35%+0.70%-1.4%
Q2 FY20266.217.45+19.97%-15.72%48.88B49.83B+1.94%+0.82%-9.3%
Q1 FY202610.8212.58+16.27%+5.10%48.20B49.49B+2.68%+1.49%+0.0%
Q4 FY20253.103.33+7.42%-13.28%49.84B49.31B-1.07%+8.51%+5.8%
Q3 FY20254.936.03+22.31%-27.96%49.38B50.09B+1.43%+10.95%-1.1%
Q2 FY20258.918.84-0.79%-12.65%48.19B49.42B+2.55%+13.23%-12.1%
Q1 FY202511.4111.97+4.91%+12.50%46.30B48.77B+5.32%+14.53%+2.1%
Q4 FY20243.803.84+1.05%-31.67%44.95B45.44B+1.09%+6.55%+2.7%
Q3 FY20249.668.37-13.35%-6.90%43.47B45.15B+3.86%+5.36%—
Q2 FY202410.0110.12+1.10%+11.95%42.99B43.65B+1.53%-0.06%—
Q1 FY202410.5310.64+1.04%+12.47%42.49B42.58B+0.20%+0.96%—
Q4 FY20235.555.62+1.26%+7.46%42.09B42.65B+1.31%+6.81%—
Q3 FY20238.458.99+6.39%+19.39%41.97B42.85B+2.08%+7.29%—
Q2 FY20238.809.04+2.73%+12.44%41.50B43.67B+5.23%+13.05%—
Q1 FY20239.269.46+2.16%+14.67%40.83B42.17B+3.28%+10.70%—
Q4 FY20225.205.23+0.58%+1.75%39.77B39.93B+0.39%+9.15%—
Q3 FY20227.157.53+5.31%+10.90%39.29B39.94B+1.65%+11.49%+1.9%
Q2 FY20227.748.04+3.88%+14.37%37.91B38.63B+1.89%+14.12%-7.8%
Q1 FY20227.818.25+5.63%+17.69%37.39B38.10B+1.87%+17.63%+2.1%
Q4 FY20215.115.14+0.59%+102.36%37.33B36.58B-2.00%+14.95%-2.6%
Q3 FY20216.376.79+6.59%+61.67%35.30B35.82B+1.47%+14.97%+7.6%
Q2 FY20216.337.03+11.06%-23.59%35.32B33.85B-4.16%+15.67%-1.7%
Q1 FY20216.517.01+7.68%+8.18%29.90B32.39B+8.32%+9.33%+0.8%
Q4 FY20202.522.54+0.79%-34.54%30.87B31.82B+3.08%+16.12%-7.2%
Q3 FY20204.154.20+1.20%-13.76%30.79B31.16B+1.20%+16.81%-4.2%
Q2 FY20208.879.20+3.72%+98.28%28.25B29.26B+3.60%+14.91%+6.2%
Q1 FY20206.486.480.00%+7.46%29.62B29.62B0.00%+20.09%+4.2%
Q4 FY20193.883.880.00%+59.02%27.41B27.41B0.00%+17.26%-6.0%
Q3 FY20194.824.87+1.04%+27.82%26.40B26.67B+1.04%+14.72%—
Q2 FY20194.614.64+0.65%+9.18%25.30B25.47B+0.65%+10.99%—
Q1 FY20195.816.03+3.79%+11.46%23.77B24.67B+3.79%+9.44%—
Q4 FY20182.202.44+10.91%+89.15%21.07B23.37B+10.91%+3.05%—
Q3 FY20183.703.81+2.97%+43.77%22.58B23.25B+2.97%+3.68%+3.8%
Q2 FY20184.164.25+2.16%+26.11%22.46B22.94B+2.16%+2.39%+0.7%
Q1 FY20184.885.41+10.86%+15.60%20.33B22.54B+10.86%+0.05%+6.1%
Q4 FY20171.271.29+1.57%-26.70%22.33B22.68B+1.57%+4.39%+2.0%
Q3 FY20172.422.65+9.50%+8.16%20.48B22.43B+9.50%+4.72%+5.4%
Q2 FY20173.233.37+4.33%+1.20%21.48B22.41B+4.33%+4.43%-3.0%
Q1 FY20173.864.68+21.24%+35.26%18.58B22.53B+21.24%+11.03%+3.8%
Q4 FY20161.611.76+9.32%+54.39%19.86B21.73B+9.38%+7.62%+4.2%
Q3 FY20162.472.45-0.81%-10.26%21.58B21.41B-0.76%+7.60%+4.7%
Q2 FY20163.233.33+3.10%+7.42%20.81B21.46B+3.10%+7.20%-2.7%
Q1 FY20163.323.46+4.22%+10.19%19.47B20.29B+4.22%+6.49%-1.6%
Q4 FY20151.201.14-5.00%-34.10%21.25B20.19B-5.00%+6.34%-4.7%
Q3 FY20152.332.73+17.17%+15.68%16.99B19.90B+17.17%+7.25%-2.0%
Q2 FY20152.773.10+11.91%+27.05%17.88B20.02B+11.91%+8.35%+0.7%
Q1 FY20152.673.14+17.60%+36.52%16.20B19.05B+17.60%+6.67%-2.0%
Q4 FY20141.721.73+0.58%+98.85%18.87B18.98B+0.58%+8.04%-3.0%
Q3 FY20142.272.36+3.96%+12.38%17.85B18.56B+3.96%+3.27%+1.8%
Q2 FY20142.262.44+7.96%-6.15%17.11B18.47B+7.96%+3.81%-0.1%
Q1 FY20142.122.30+8.49%-21.77%16.46B17.86B+8.49%+0.97%+5.5%
Q4 FY20130.870.870.00%-15.53%17.57B17.57B0.00%+13.10%+1.3%
Q3 FY20131.822.10+15.38%+0.48%15.57B17.97B+15.38%+17.04%-3.3%
Q2 FY20132.112.60+23.22%+27.45%14.44B17.80B+23.22%+15.50%-0.1%
Q1 FY20132.382.94+23.53%+25.64%14.32B17.69B+23.53%+14.74%+5.8%
Q4 FY20120.951.03+8.42%+4.04%14.33B15.54B+8.42%+1.43%+1.6%
Q3 FY20121.842.09+13.59%+18.08%13.52B15.35B+13.59%-0.29%-5.5%
Q2 FY20122.082.04-1.92%+11.48%15.71B15.41B-1.92%+2.03%-12.1%
Q1 FY20122.272.34+3.08%-0.43%14.95B15.42B+3.08%+3.50%-0.5%
Q4 FY20111.120.99-11.61%-25.56%17.33B15.32B-11.61%+4.57%-4.8%
Q3 FY20111.681.77+5.36%+1.72%14.62B15.40B+5.36%+5.48%+3.9%
Q2 FY20111.801.83+1.67%+9.58%14.85B15.10B+1.67%+4.45%-6.6%
Q1 FY20111.872.35+25.67%+20.51%11.85B14.89B+25.67%-1.35%+3.5%
Q4 FY20101.231.33+8.13%+14.66%13.55B14.65B+8.13%-23.09%+1.4%
Q3 FY20101.581.74+10.13%-2.25%13.23B14.60B+10.32%-5.36%+0.5%
Q2 FY20101.551.67+7.74%+11.33%13.42B14.46B+7.74%-6.20%-3.7%
Q1 FY20101.671.95+16.77%+20.37%12.93B15.10B+16.77%-0.30%+2.7%
Q4 FY20091.021.16+13.73%+78.46%16.75B19.05B+13.73%+26.39%+1.2%
Q3 FY20091.371.78+29.93%+11.25%11.87B15.43B+29.93%+3.10%-0.9%
Q2 FY20091.431.50+4.90%+4.17%14.69B15.41B+4.90%-1.62%-5.7%
Q1 FY20091.251.62+29.60%+51.40%11.68B15.14B+29.60%-2.64%+0.5%
Q4 FY20081.360.65-52.21%-56.95%31.53B15.07B-52.21%-3.16%+4.4%
Q3 FY20081.491.60+7.38%+10.34%13.93B14.96B+7.38%-1.79%-4.9%
Q2 FY20081.361.44+5.88%+6.67%14.80B15.67B+5.88%+2.67%+9.1%
Q1 FY20081.191.07-10.08%-15.08%17.30B15.55B-10.08%+3.15%+7.3%
Q4 FY20071.511.510.00%+18.90%15.56B15.56B0.00%+6.91%-3.7%
Q3 FY20071.441.45+0.69%+16.94%15.13B15.23B+0.69%+5.60%-1.4%
Q2 FY20071.351.350.00%+14.41%15.26B15.26B0.00%+7.83%-2.7%
Q1 FY20071.261.260.00%+14.55%15.08B15.08B0.00%+9.11%-4.1%
Q4 FY20061.271.270.00%+20.95%14.56B14.56B0.00%+27.32%-1.3%
Q3 FY20061.231.24+0.81%+21.57%14.31B14.43B+0.81%+27.61%-2.7%
Q2 FY20061.141.18+3.51%+18.00%13.67B14.15B+3.51%+25.25%-0.5%
Q1 FY20061.071.10+2.80%+17.02%13.44B13.82B+2.80%+24.50%-0.4%
Q4 FY20051.041.05+0.96%+23.53%11.32B11.43B+0.96%+67.30%-0.5%
Q3 FY20051.011.02+0.99%+21.43%11.19B11.30B+0.99%+135.37%-5.7%
Q2 FY20050.971.00+3.09%+20.48%10.96B11.30B+3.09%+145.39%-1.7%
Q1 FY20050.910.94+3.30%+16.05%10.75B11.10B+3.30%+142.67%+5.4%
Q4 FY20040.840.85+1.19%+18.06%6.75B6.83B+1.19%+59.11%-3.2%
Q3 FY20040.830.84+1.20%+23.53%4.75B4.80B+1.20%+12.70%+5.6%
Q2 FY20040.820.83+1.22%+27.69%4.55B4.60B+1.22%+11.91%-7.2%
Q1 FY20040.730.81+10.96%+37.29%4.12B4.57B+10.96%+11.56%-1.6%
Q4 FY20030.690.72+4.35%+28.57%4.12B4.29B+4.35%+7.63%+3.9%
Q3 FY20030.660.68+3.03%+28.30%4.14B4.26B+3.03%+19.06%-8.0%
Q2 FY20030.620.65+4.84%+30.00%3.92B4.11B+4.84%+41.87%-4.4%
Q1 FY20030.590.590.00%+25.53%4.10B4.10B0.00%+45.79%+2.1%
Q4 FY20020.550.56+1.82%+16.67%3.92B3.99B+1.82%+49.81%-3.7%
Q3 FY20020.500.53+6.00%—3.38B3.58B+6.00%—+0.9%
Q2 FY20020.490.50+2.04%—2.84B2.90B+2.04%—-9.3%
Q1 FY20020.420.47+11.90%—2.51B2.81B+11.90%—-5.7%
Q4 FY2001—0.42———2.66B——-0.4%
Q4 FY20010.450.48+6.67%—2.48B2.66B+7.20%—+4.2%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Beat record

On average, analysts' EPS estimate was 11.5% off the result, either way, and their revenue estimate 2.1%, over the last 12 quarters.

EPS beats
84 / 100
Revenue beats
83 / 100
Average EPS surprise, last 12
+9.1%
Since
February 2002

See also:Forecast,EPS,Income statement

Common questions about Elevance Health's earnings

Source: Financial Modeling Prep